Cellectis
CLLS
31 hedge funds and large institutions have $18.1M invested in Cellectis in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
500% more call options, than puts
Call options by funds: $6K | Put options by funds: $1K
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
4.55% less ownership
Funds ownership: 25.2% → 20.66% (-4.5%)
14% less funds holding
Funds holding: 36 → 31 (-5)
34% less capital invested
Capital invested by funds: $27.6M → $18.1M (-$9.45M)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$97K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$19K |
| 3 |
JP Morgan Chase
New York
|
+$8.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8.43K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Bpifrance
Maisons Alfort, Cedex,
France
|
-$4.3M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$498K |
| 3 |
Millennium Management
New York
|
-$140K |
| 4 |
D.E. Shaw & Co
New York
|
-$61.9K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$54.8K |
CLLS Hedge Fund Activity: Q3 2023 in Review
31 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2023, worth a combined $18.1M — down 34% from $27.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CLLS and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was LPL Financial, adding an estimated $97K. The largest seller was Bpifrance, exiting entirely with an estimated $4.3M sold.
- 31 institutional investors held Cellectis (CLLS) as of Q3 2023, down from 36 in Q2 2023.
- Funds reported $18.1M of Cellectis stock for Q3 2023, down 34% quarter-over-quarter.
- 2 funds opened new Cellectis positions in Q3 2023 and 7 closed out, a net change of -5 holders.
- The largest Cellectis buyer in Q3 2023 was LPL Financial, an estimated $97K added.
- The largest Cellectis seller in Q3 2023 was Bpifrance, an estimated $4.3M sold.
Based on aggregated 13F filings for Q3 2023.